In the race to contain SARS-CoV-2, efficient detection and triage of infected patients must rely on rapid and reliable testing. In this work we performed the first evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 Panel (QIAstat-SARS) for SARS-CoV-2 detection. This assay is the first rapid multiplex PCR (mPCR) assay including SARS-CoV-2 detection, and is fully compatible with a non-PCR trained laboratory or point-of-care (POC) testing.This evaluation was performed using 69 primary clinical samples (66 NPS, 1 BAL and 1 tracheal aspirate and 1 bronchial aspirate) comparing the SARS-CoV-2 detection with the currently WHO recommended RT-PCR (WHO-PCR) workflow. Additionally, a comparative limit of detection (LoD) assessment was performed between QIAstat-SARS and the WHO-PCR using a quantified clinical sample. Compatibility of sample pre-treatment for viral neutralisation or viscous samples with the QIAstat-SARS system were also tested.The QIAstat-Dx Respiratory SARS-CoV-2 Panel demonstrated a comparable sensitivity to the WHO recommended assay with a limit of detection at 1000 copies/mL. The overall percent agreement between QIAstat-Dx SARS and WHO-PCR on 69 clinical samples was 97% with a sensitivity at 100% (40/40) and specificity at 93% (27/29). No cross reaction was encountered for any other respiratory viruses or bacteria included in the panel.The QIAstat-SARS rapid multiplex-PCR panel provides a highly sensitive, robust and accurate assay for rapid detection of SARS-CoV-2. This assay allows rapid decisions even in non-PCR trained laboratory or point-of-care testing, allowing innovative organisation.
Copyright © 2020 Visseaux et al.
Multicenter Evaluation of the QIAstat-Dx Respiratory Panel for Detection of Viruses and Bacteria in Nasopharyngeal Swab Specimens.J Clin Microbiol. 2020 Apr 23;58(5):e00155-20. doi: 10.1128/JCM.00155-20. Print 2020 Apr 23. J Clin Microbiol. 2020. PMID: 32132186 Free PMC article.
Multicenter Evaluation of QIAstat-Dx Respiratory Panel V2 for Detection of Viral and Bacterial Respiratory Pathogens.J Clin Microbiol. 2020 May 26;58(6):e01793-19. doi: 10.1128/JCM.01793-19. Print 2020 May 26. J Clin Microbiol. 2020. PMID: 32229601
Clinical evaluation of AusDiagnostics SARS-CoV-2 multiplex tandem PCR assay.J Clin Virol. 2020 May 19;128:104448. doi: 10.1016/j.jcv.2020.104448. Online ahead of print. J Clin Virol. 2020. PMID: 32460173 Free PMC article.
[Enhanced-real time PCR: a highly sensitive method for SARS-coronavirus detection].Beijing Da Xue Xue Bao Yi Xue Ban. 2006 Apr 18;38(2):211-3. Beijing Da Xue Xue Bao Yi Xue Ban. 2006. PMID: 16617369 Review. Chinese.
Features, Evaluation and Treatment Coronavirus (COVID-19).2020 Apr 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan–. StatPearls. 2020 Jan–. PMID: 32150360 Free Books & Documents. Review.